ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-31

Results: 1-25/31

Adalimumab - Antiarthritic treatment of IBD

Authors: Sorbera, LA Rabasseda, X Castaner, RM

Citation: La. Sorbera et al., Adalimumab - Antiarthritic treatment of IBD, DRUG FUTURE, 26(7), 2001, pp. 639-646

Bimatoprost - Antiglaucoma

Authors: Sorbera, LA Leeson, PA Rabasseda, X Castaner, J

Citation: La. Sorbera et al., Bimatoprost - Antiglaucoma, DRUG FUTURE, 26(5), 2001, pp. 433-439

Pramlintide acetate - Antidiabetic

Authors: Norman, P Rabasseda, X Leeson, PA

Citation: P. Norman et al., Pramlintide acetate - Antidiabetic, DRUG FUTURE, 26(5), 2001, pp. 444-452

UT-15 - Treatment of pulmonary hypertension, treatment of peripheral vascular disease

Authors: Sorbera, LA Rabasseda, X Castaner, J

Citation: La. Sorbera et al., UT-15 - Treatment of pulmonary hypertension, treatment of peripheral vascular disease, DRUG FUTURE, 26(4), 2001, pp. 364-374

Vilazodone hydrochloride - Antidepressant - 5-HT1A partial agonist - 5-HT reuptake inhibitor

Authors: Sorbera, LA Rabasseda, X Silvestre, J Castaner, J

Citation: La. Sorbera et al., Vilazodone hydrochloride - Antidepressant - 5-HT1A partial agonist - 5-HT reuptake inhibitor, DRUG FUTURE, 26(3), 2001, pp. 247-252

Vardenafil - Treatment of erectile dysfunction - Phosphodiesterase 5 inhibitor

Authors: Sorbera, LA Martin, L Rabasseda, X Castaner, J

Citation: La. Sorbera et al., Vardenafil - Treatment of erectile dysfunction - Phosphodiesterase 5 inhibitor, DRUG FUTURE, 26(2), 2001, pp. 141-144

KW-6002 - Antiparkinsonian - Antidepressant - Adenosine A(2A) antagonist

Authors: Rabasseda, X Sorbera, LA Martin, L Leeson, PA Castaner, J

Citation: X. Rabasseda et al., KW-6002 - Antiparkinsonian - Antidepressant - Adenosine A(2A) antagonist, DRUG FUTURE, 26(1), 2001, pp. 20-24

TMX-67 - Treatment of gout and hyperuricemia - Xanthine oxidase inhibitor

Authors: Sorbera, LA Revel, L Rabasseda, X Castaner, J

Citation: La. Sorbera et al., TMX-67 - Treatment of gout and hyperuricemia - Xanthine oxidase inhibitor, DRUG FUTURE, 26(1), 2001, pp. 32-38

Barnidipine

Authors: Acuna, C Rabasseda, X

Citation: C. Acuna et X. Rabasseda, Barnidipine, DRUGS TODAY, 37, 2001, pp. 1-30

Almotriptan in the treatment of migraine

Authors: Rabasseda, X

Citation: X. Rabasseda, Almotriptan in the treatment of migraine, DRUGS TODAY, 37(6), 2001, pp. 359-375

Nateglinide: A structurally novel, short-acting, hypoglycemic agent

Authors: Norman, P Rabasseda, X

Citation: P. Norman et X. Rabasseda, Nateglinide: A structurally novel, short-acting, hypoglycemic agent, DRUGS TODAY, 37(6), 2001, pp. 411-426

Oxcarbazepine: Anticonvulsant profile and safety

Authors: Rabasseda, X

Citation: X. Rabasseda, Oxcarbazepine: Anticonvulsant profile and safety, DRUGS TODAY, 37(5), 2001, pp. 333-355

Desloratadine: A preclinical and clinical overview

Authors: Norman, P Dihlmann, A Rabasseda, X

Citation: P. Norman et al., Desloratadine: A preclinical and clinical overview, DRUGS TODAY, 37(4), 2001, pp. 215-227

Migraine headache treatment with eletriptan, a second-generation serotoninreceptor agonist

Authors: Cole, P Rabasseda, X

Citation: P. Cole et X. Rabasseda, Migraine headache treatment with eletriptan, a second-generation serotoninreceptor agonist, DRUGS TODAY, 37(3), 2001, pp. 159-171

Amoxicillin-sulbactam: A clinical and therapeutic review

Authors: Acuna, C Rabasseda, X

Citation: C. Acuna et X. Rabasseda, Amoxicillin-sulbactam: A clinical and therapeutic review, DRUGS TODAY, 37(3), 2001, pp. 193-210

Almotriptan in the treatment of migraine

Authors: Rabasseda, X

Citation: X. Rabasseda, Almotriptan in the treatment of migraine, DRUGS TODAY, 37(1), 2001, pp. 5-21

Natalizumab. Treatment of IBD, Treatment of multiple sclerosis

Authors: Sorbera, LA Martin, L Rabasseda, X

Citation: La. Sorbera et al., Natalizumab. Treatment of IBD, Treatment of multiple sclerosis, DRUG FUTURE, 25(9), 2000, pp. 917-921

MK-0826. Carbapenem antibiotic.

Authors: Sorbera, LA Rabasseda, X Castaner, J Leeson, PA

Citation: La. Sorbera et al., MK-0826. Carbapenem antibiotic., DRUG FUTURE, 25(8), 2000, pp. 795-802

Gemtuzumab ozogamicin - Treatment of acute myeloid leukemia

Authors: Rabasseda, X Graul, A Castaner, RM

Citation: X. Rabasseda et al., Gemtuzumab ozogamicin - Treatment of acute myeloid leukemia, DRUG FUTURE, 25(7), 2000, pp. 686-692

Tiotropium bromide - Treatment of COPD, bronchodilator, muscarinic antagonist

Authors: Norman, P Graul, A Rabasseda, X Castaner, J

Citation: P. Norman et al., Tiotropium bromide - Treatment of COPD, bronchodilator, muscarinic antagonist, DRUG FUTURE, 25(7), 2000, pp. 693-699

ABT-773 - Ketolide antibiotic

Authors: Sorbera, LA Rabasseda, X Castaner, J

Citation: La. Sorbera et al., ABT-773 - Ketolide antibiotic, DRUG FUTURE, 25(5), 2000, pp. 445-453

Conivaptan hydrochloride. Treatment of heart failure, Treatment of hyponatremia, Vasopressin V-1a/V-2 antagonist.

Authors: Norman, P Leeson, PA Rabasseda, X Castaner, J Castaner, RM

Citation: P. Norman et al., Conivaptan hydrochloride. Treatment of heart failure, Treatment of hyponatremia, Vasopressin V-1a/V-2 antagonist., DRUG FUTURE, 25(11), 2000, pp. 1121-1130

Rufinamide. Antiepileptic, Treatment of neurogenic pain.

Authors: Sorbera, LA Leeson, PA Rabasseda, X Castaner, J

Citation: La. Sorbera et al., Rufinamide. Antiepileptic, Treatment of neurogenic pain., DRUG FUTURE, 25(11), 2000, pp. 1145-1149

LY-333531 mesylate hydrate - Symptomatic antidiabetic - Protein kinase C inhibitor

Authors: Sorbera, LA Silvestre, J Rabasseda, X Castaner, J

Citation: La. Sorbera et al., LY-333531 mesylate hydrate - Symptomatic antidiabetic - Protein kinase C inhibitor, DRUG FUTURE, 25(10), 2000, pp. 1017-1026

The role of hyaluronic acid in the management of periodontal disease

Authors: Rabasseda, X

Citation: X. Rabasseda, The role of hyaluronic acid in the management of periodontal disease, DRUGS TODAY, 36, 2000, pp. 1-20

Risultati: 1-25 | 26-31